The introduction of anti-glaucoma medications has reduced the need for filtration surgery, according to study results published online ahead of print by Eye.
The introduction of anti-glaucoma medications has reduced the need for filtration surgery, according to study results published online ahead of print by Eye.
P.A. Keane of the Department of Ophthalmology at Waterford Regional Hospital, Ireland and colleagues conducted a 20-year retrospective review of patients undergoing glaucoma filtration surgery (n=760) at Waterford Regional Hospital between January 1986 and December 2005.
Over the review period, three new anti-glaucoma medicines became available. The number of filtration surgeries performed fell annually: from 1986–1995, the mean annual figure was 23.75 per surgeon; by the 1998–2005 period, this had fallen to 12.69 procedures per surgeon per year. The age of patients undergoing surgery did not decrease across the review period.
The team concluded that, as the decrease in filtration surgeries was not correlated to patient age, the introduction of topical anti-glaucoma medication was the most likely cause for the reduction, although it remains unclear whether this is an absolute reduction or merely a delay in the need for surgery.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.